Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001415889-25-024319

Chief Scientific Officer acquired 22,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Higgins Jack Chief Scientific Officer 2025-09-10 Option exercise +22,000 $1.35 $29,700 40,729 D
Derivatives
Higgins Jack Chief Scientific Officer 2025-09-10 Option exercise · Employee Stock option (right to buy) −22,000 151,840 D
Loading xslF345X05/form4-09122025_010912.xml…